lysophosphatidic acid has been researched along with Lymph Node Metastasis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, CC; Chen, WM; Huang, YL; Jou, YC; Kanaho, Y; Lee, H; Lin, YC; Lu, KY; Ohbayashi, N; Shen, CH; Shen, TL | 1 |
Bar-Eli, M; Calderone, TL; Davies, MA; Gershenwald, JE; Mills, GB; Mu, H; Prieto, VG; Wang, H | 1 |
2 other study(ies) available for lysophosphatidic acid and Lymph Node Metastasis
Article | Year |
---|---|
LPA
Topics: Animals; Cell Line, Tumor; Disease Progression; Eukaryotic Initiation Factor-2; Humans; Lymphangiogenesis; Lymphatic Metastasis; Lysophospholipids; Male; Mice; Mice, Nude; Neoplasm Transplantation; Phosphoric Diester Hydrolases; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Receptors, Lysophosphatidic Acid; Signal Transduction; Vascular Endothelial Growth Factor C | 2018 |
Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells.
Topics: Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Interleukin-8; Lymphangiogenesis; Lymphatic Metastasis; Lymphatic Vessels; Lysophospholipids; Melanoma; NF-kappa B; Receptors, Lysophosphatidic Acid; RNA, Small Interfering; Sentinel Lymph Node Biopsy; Signal Transduction; Up-Regulation | 2012 |